NuCana plc American Depositary Share (NCNA)

About NCNA

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate concentrations of anti-cancer metabolites in cancer cell…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

10

Website

www.nucana.com/

Fundamentals

1-day range

$1.34$1.66

Market cap

$5.66M

P/E (trailing)

0.01

P/E (forward)

-0.16

EPS (trailing)

$-0.00

Dividend yield

—

Beta

2.34

Avg. volume

52.1K

NuCana plc American Depositary Share Competitors

Chosen by industry and closest market cap.

• NCNA

  NuCana plc American Depositary Share

  $1.79

  ▲ 21.43%
  Market cap $5.66MP/E 0.01
  $1.21$7.22
• BGMS

  Bio Green Med Solution Inc. Common Stock

  $0.86

  ▼ 3.37%
  Market cap $5.35MP/E —
  $0.5664$8.82
• GOVX

  GeoVax Labs Inc. Common Stock

  $0.7195

  ▲ 0.35%
  Market cap $5.31MP/E —
  $0.59$19.2
• LABT

  Lakewood-Amedex Biotherapeutics Inc. Common Stock

  $2.3

  ▼ 4.56%
  Market cap $5.28MP/E —
  $0.366$9.82
• PULM

  Pulmatrix Inc. Common Stock

  $1.51

  ▼ 0.66%
  Market cap $6.06MP/E —
  $1.16$5.5
• APVO

  Aptevo Therapeutics Inc. Common Stock

  $2.36

  ▼ 2.48%
  Market cap $6.18MP/E 0.00
  $2.3$48.78
• HCWB

  HCW Biologics Inc. Common Stock

  $3.39

  ▲ 6.94%
  Market cap $6.19MP/E —
  $1.5$39.96

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• NuCana Has Been Granted European Patent Number EP3683225 Titled "NEW 2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS"
  benzinga · 8/28/2026
• 12 Health Care Stocks Moving In Friday's After-Market Session
  Benzinga · 8/28/2026
• NuCana Has Been Granted European Patent Number EP3683225 Titled "NEW 2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS"
  Benzinga · 8/28/2026
• 12 Health Care Stocks Moving In Friday's After-Market Session
  Benzinga · 8/7/2026

• Levy Elliott M. · June 19, 2026 · Disposition

  23.81M
• Bloss Jeffrey D. · June 19, 2026 · Disposition

  36.54M
• Bruce Theresa Margaret Ms · April 15, 2026 · Grant

  132.60M

Institutional Ownership

March 31, 2026

Total shares held

56.5K

Total value held

$60.5K

Institutional holders

8